Revapharma LLP - pharma in New Delhi, Delhi, India. Directors, charges & compliance details.
LLPIN AAR-9430 Incorporated 17 February 2020 ROC Delhi HQ New Delhi, Delhi, India
Active Limited Liability Partnership pharma
Revenue · FY 2023
₹1.14 Cr
▼ 84% YoY
EBITDA · FY 2023
₹11.78 Lakh
EBITDA margin 10.3%
Contribution obligation
₹1 Lakh
As per LLP agreement
Open charges
₹50 Lakh
Secured borrowings
LLP age
6 yrs
Est. 2020
Designated partners
2
As per MCA filings
Active GSTINs
2
GST registered
Last financials
Mar 2024
Balance sheet date

About Revapharma LLP

Data last updated:

Revapharma LLP is a limited liability partnership (LLP) based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 February 2020 and has been in existence for over 6 years.

The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAR-9430. Its GSTIN is 07ABBFR0512N1ZA (Delhi). The LLP holds 2 GST registrations, all of them active.

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Shishant Gupta and Gurpreet Sandhu Singh.

Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at A – 4 Part A Mahipalpur Extended Abadi Of Village Mahipalpur, Main Vasant Kunj Road Opp. To Jagannath Complex, New Delhi, Delhi, India – 110037.

As per the financials filed for FY 2023, the LLP reported a revenue of ₹1.14 Cr, a decline of 84% compared to the previous year. For the same year it recorded EBITDA of ₹11.78 Lakh (EBITDA margin 10.3%).

As per MCA filings, the LLP has open charges of ₹50 Lakh on record. Court records list 1 case involving the LLP, including 1 filed against it.

For more details, the LLP can be reached via its website revapharma.com.

Company details

LLPIN AAR-9430
Incorporation Date 17 February 2020
Total Obligation of Contribution ₹1 Lakh
ROC Delhi
Company Status Active

Contact details

Revapharma LLP's registered office is in New Delhi, Delhi.

  • Social Media
  • Registered Address
    A – 4 Part A Mahipalpur Extended Abadi Of Village Mahipalpur, Main Vasant Kunj Road Opp. To Jagannath Complex, New Delhi, Delhi, India – 110037
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Revapharma LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Revapharma LLP

FY 2024 filings available

Revapharma LLP reported revenue of ₹1.14 Cr (down 84% YoY) for FY 2023.

Revenue · FY 2023
₹1.14 Cr ▼ 84%
EBITDA · FY 2023
₹11.78 Lakh margin 10.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 84%
EBITDA CAGR growth
1 year
▲ 257%
3 years · compounded
▲ 68%

Revenue fell 84% in the latest year. EBITDA rose 257% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Revapharma LLP, buy the company report.

Designated partners of Revapharma LLP

Revapharma has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Shishant GuptaDesignated Partner04 Jun 20224 Years 5 MonthsCurrent
Gurpreet Sandhu SinghDesignated Partner17 Feb 20206 Years 9 MonthsCurrent

Peer comparison

Revapharma LLP is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Xenosys Biotech Private Limited₹1.15 Cr (FY 2025)-42.0%Sanand, Gujarat, India
Abm Lab Private Limited₹1.15 Cr (FY 2020)13.0%New Delhi, Delhi, India
Bonjour Health Care Private Limited₹1.15 Cr (FY 2025)11.0%New Delhi, Delhi, India
Foray Life Care Private Limited₹1.15 Cr (FY 2025)51.0%Bengaluru, Karnataka, India
Taizi Pharma Private Limited₹1.15 Cr (FY 2023)184.0%Bangalore, Karnataka, India
Revapharma LLPthis company₹1.14 Cr (FY 2023)-84.0%New Delhi, Delhi, India
Osr Pharmaceuticals Private Limited₹1.14 Cr (FY 2025)11.0%Delhi, India
Vrihad Health Care Private Limited₹1.14 Cr (FY 2024)66.0%Chhattisgarh, India
Pyramid Formulations Private Limited₹1.14 Cr (FY 2023)16.0%Salem, Tamil Nadu, India
Life Line Biotech Limited₹1.14 Cr (FY 2025)-66.0%New Delhi, Delhi, India
Ytiliga Private Limited₹1.14 Cr (FY 2024)30.0%Delhi, India

To see the full peer comparison of Revapharma LLP, buy the company report.

Charges & borrowings

Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Daimler Financial Services India Private Limited₹0.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Feb 2021100438533Daimler Financial Services India Private Limited₹50 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Revapharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Revapharma has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
07ABBFR0512N1ZADelhiActive13 Jun 2020
24ABBFR0512N1ZEGujaratActive08 Nov 2023

To see the full GST registrations and return filing status of Revapharma LLP, buy the company report.

Recent activity

Revapharma LLP has 3 designated partner changes on record since 2020: 2 appointments and 1 cessation. The latest: Nizar Balan ceased to be Designated Partner on 04 Jun 2022.

AGM
Revapharma Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records.
Filing
Revapharma Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi I.
Ceased
Nizar Balan ceased to be Designated Partner.
Appointed
Shishant Gupta was appointed as Designated Partner.
Charges
A charge with Daimler Financial Services India Private Limited amounted to Rs. 50.00 Lakh with Charge ID 100438533 was registered on 26 Feb 2021.
Appointed
Gurpreet Sandhu Singh was appointed as Designated Partner.
Incorporation
17 Feb 2020
Revapharma Llp was registered on 17 Feb 2020 with Roc Delhi I & aged 6 years 9 months as per MCA records.

Frequently asked questions

Revapharma is an active limited liability partnership based in New Delhi, Delhi, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 17 February 2020 (6+ years old) and is registered under LLPIN AAR-9430.

Revapharma has 2 current designated partners:

The latest financial statements of Revapharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2024. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Revapharma is 07ABBFR0512N1ZA, registered in Delhi. The LLP has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24ABBFR0512N1ZE (Gujarat).

The LLPIN (Limited Liability Partnership Identification Number) of Revapharma is AAR-9430. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Revapharma has 1 court case on record: 1 filed against it.

Revapharma was incorporated on 17 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Revapharma by revenue are Xenosys Biotech Private Limited, Abm Lab Private Limited, Bonjour Health Care Private Limited, Foray Life Care Private Limited, Taizi Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).

Nizar Balan ceased to be Designated Partner on 04 Jun 2022. Shishant Gupta was appointed as Designated Partner on 04 Jun 2022. Gurpreet Sandhu Singh was appointed as Designated Partner on 17 Feb 2020.

Revapharma can be reached through the website revapharma.com. Its registered office is in New Delhi, Delhi, India.

The registered office of Revapharma is at A – 4 Part A Mahipalpur Extended Abadi Of Village Mahipalpur, Main Vasant Kunj Road Opp. To Jagannath Complex, New Delhi, Delhi, India – 110037.